A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
11/26/2025
BreakingCataractCornealDiagnosticSurgicalTransplant
Cure Blindness Project’s 2025 Holiday Catalog Encourages Shoppers to Give Gift of Sight
Cure Blindness Project on Nov. 18 launched its 2025 Holiday Gift Guide, which the group describes as giving shoppers a thoughtful, sustainable, and hassle-free charity gift option. The catalog offe...
11/26/2025
BreakingCataractGlaucomaOcular CancerRefractiveRetinaSurgical
Bascom Palmer Eye Institute Opens Location in Abu Dhabi
The Bascom Palmer Eye Institute, part of the University of Miami Health System, announced that it was opening its first international location in Abu Dhabi, United Arab Emirates, in November. The p...
11/26/2025
BreakingRetinaSurgical
Assistance Fund Charity Launches Aid Program for MacTel Treatment
The Assistance Fund, a charitable organization that helps patients facing high out-of-pocket medical costs, announced Nov. 3 a new financial aid program for people living with macular telangiectasi...
11/19/2025
AAOMeetingNewsletterRetina
AAO Retina Sessions Delve into Wide-field Imaging, Diabetic Eye Disease, and More
Approximately 2,300 doctors attended the Retina Subspecialty Day at the 2025 AAO meeting, and many stayed to take part in retina sessions during the remaining days of the conference. Highlights of ...
11/26/2025
BreakingDealsDry Eye
Cartwheel to License ClearSight’s OTC Pink Eye Treatment
Cartwheel, of Boston, Massachusetts, reported Nov. 12 that it had signed a letter of intent to license ClearSight Therapeutics’ over-the-counter (OTC) pink eye treatment beginning in 2027. ClearSig...
11/26/2025
BreakingGene TherapyRetina
Coave Unveils Lead Gene Therapy Program for Retinal Vascular Diseases
France’s Coave Therapeutics announced Nov. 14 the selection of its lead gene therapy program, CoTx-101, targeting retinal vascular diseases such as wet age-related macular degeneration and diabetic...
11/26/2025
BreakingDealsRetina
Curative Biotech Seeks Strategic Partner to Advance Metformin Eye Drops for AMD
Curative Biotechnology issued a letter to shareholders Nov. 18, outlining its plan to seek a strategic partner to advance the metformin-based eye drops it licensed from the National Eye Institute. ...
11/26/2025
BiosimilarsBreakingRegulationRetina
Xbrane Plans to Resubmit BLA to US FDA in March 2026 for Lucentis Biosimilar
Sweden’s Xbrane Biopharma announced Nov. 19 that it would resubmit the biologics license application (BLA) for its Lucentis (ranibizumab) biosimilar to the US FDA in March 2026. A complete response...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.